Section Arrow
PRME.NASDAQ
- Prime Medicine
Quotes are at least 15-min delayed:2025/11/19 12:25 EST
Regular Hours
Last
 3.825
+0.275 (+7.75%)
Day High 
3.95 
Prev. Close
3.55 
1-M High
6.3 
Volume 
3.25M 
Bid
3.82
Ask
3.83
Day Low
3.55 
Open
3.56 
1-M Low
3.17 
Market Cap 
640.81M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.75 
20-SMA 4.3 
50-SMA 4.97 
52-W High 6.94 
52-W Low 1.11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.56/-1.39
Enterprise Value
677.99M
Balance Sheet
Book Value Per Share
0.90
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.98M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NUVBNuvation Bio7.135+2.335+48.65%-- 
CYPHCypherpunk Technologies Inc.2.7298-0.2402-8.09%-- 
ASBPAspire Biopharma Holdings Inc.0.0977-0.008-7.57%-- 
OLMAOlema Pharmaceuticals20.085-0.055-0.27%-- 
RXRXRecursion Pharmaceuticals4.05-0.11-2.64%-- 
Quotes are at least 15-min delayed:2025/11/19 12:25 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.